Sage Therapeutics’ Stock Plummets 49% Following FDA Decision
August 07, 2023: Sage Therapeutics Inc. faced a significant setback as its stock price plummeted by 49% after the U.S. Food and Drug Administration
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds